Matches in Wikidata for { <http://www.wikidata.org/entity/Q59694044> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- Q59694044 description "article scientifique publié en 2008" @default.
- Q59694044 description "article" @default.
- Q59694044 description "im Mai 2008 veröffentlichter wissenschaftlicher Artikel" @default.
- Q59694044 description "wetenschappelijk artikel" @default.
- Q59694044 description "наукова стаття, опублікована в травні 2008" @default.
- Q59694044 name "Impaired CD163-mediated hemoglobin-scavenging and severe toxic symptoms in patients treated with gemtuzumab ozogamicin" @default.
- Q59694044 name "Impaired CD163-mediated hemoglobin-scavenging and severe toxic symptoms in patients treated with gemtuzumab ozogamicin" @default.
- Q59694044 type Item @default.
- Q59694044 label "Impaired CD163-mediated hemoglobin-scavenging and severe toxic symptoms in patients treated with gemtuzumab ozogamicin" @default.
- Q59694044 label "Impaired CD163-mediated hemoglobin-scavenging and severe toxic symptoms in patients treated with gemtuzumab ozogamicin" @default.
- Q59694044 prefLabel "Impaired CD163-mediated hemoglobin-scavenging and severe toxic symptoms in patients treated with gemtuzumab ozogamicin" @default.
- Q59694044 prefLabel "Impaired CD163-mediated hemoglobin-scavenging and severe toxic symptoms in patients treated with gemtuzumab ozogamicin" @default.
- Q59694044 P1104 Q59694044-098A4D8D-2F53-4170-B417-B36C82A6C143 @default.
- Q59694044 P1433 Q59694044-ED2EDFEC-B19C-4D43-B332-1AC396DA7CE7 @default.
- Q59694044 P1476 Q59694044-7BC522EC-4089-4A0C-95AA-DA2ACD346685 @default.
- Q59694044 P2093 Q59694044-B18B90F1-2332-4417-98E7-BCF30E8A5028 @default.
- Q59694044 P2093 Q59694044-BC85B871-BC64-4A9B-B209-37535782744F @default.
- Q59694044 P2093 Q59694044-BE648F71-5B24-4E1A-9F35-831E46D3531D @default.
- Q59694044 P2093 Q59694044-FB2DD916-3ED4-4912-A4E9-FAF59CA046CB @default.
- Q59694044 P304 Q59694044-30D9DD2D-1FBC-4458-89A4-B044952AD772 @default.
- Q59694044 P31 Q59694044-CE525456-EC16-423C-9CFE-A0D3C864550D @default.
- Q59694044 P356 Q59694044-8DE600BF-979F-4ECC-90AE-F848CB495981 @default.
- Q59694044 P407 Q59694044-9A793B18-8284-4718-A49F-F57A3B5C4114 @default.
- Q59694044 P433 Q59694044-7A68E1D1-44E5-49FB-B145-60C451E8CF6B @default.
- Q59694044 P478 Q59694044-8D975040-9E3F-4AC2-8678-0AD0B10A4B67 @default.
- Q59694044 P50 Q59694044-6B502CFA-FA22-4382-B32E-A768BF8AFB2B @default.
- Q59694044 P50 Q59694044-6F22DED2-AD8F-41DA-AF0D-214CA7DF6E83 @default.
- Q59694044 P50 Q59694044-917AA069-91BE-4BC7-870B-9529C4DBF653 @default.
- Q59694044 P50 Q59694044-96B423DF-6E1C-4CE7-8A41-E2EA1153039C @default.
- Q59694044 P577 Q59694044-4CAB5E31-6C8C-44B6-9735-4E14DBDCCE36 @default.
- Q59694044 P698 Q59694044-8C477AF8-CAC7-4E6F-BB34-77BADA1D5C7C @default.
- Q59694044 P356 BLOOD-2007-09-114165 @default.
- Q59694044 P698 18550848 @default.
- Q59694044 P1104 "+5" @default.
- Q59694044 P1433 Q885070 @default.
- Q59694044 P1476 "Impaired CD163-mediated hemoglobin-scavenging and severe toxic symptoms in patients treated with gemtuzumab ozogamicin" @default.
- Q59694044 P2093 "Birgitte Lausen" @default.
- Q59694044 P2093 "Knud Bendix" @default.
- Q59694044 P2093 "Maciej Bogdan Maniecki" @default.
- Q59694044 P2093 "Ove Juul Nielsen" @default.
- Q59694044 P304 "1510-1514" @default.
- Q59694044 P31 Q13442814 @default.
- Q59694044 P356 "10.1182/BLOOD-2007-09-114165" @default.
- Q59694044 P407 Q1860 @default.
- Q59694044 P433 "4" @default.
- Q59694044 P478 "112" @default.
- Q59694044 P50 Q30510054 @default.
- Q59694044 P50 Q40506155 @default.
- Q59694044 P50 Q50212919 @default.
- Q59694044 P50 Q67984452 @default.
- Q59694044 P577 "2008-06-11T00:00:00Z" @default.
- Q59694044 P698 "18550848" @default.